Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Defense Secretary Pete Hegseth jokingly said any surge in takeout deliveries to the Pentagon — a phenomenon that has accurately predicted the start of major geopolitical events — could be him ordering ...

Mac Mart in Center City Philadelphia received 600 tubs of French onion dip it never ordered. Owner Marti Lieberman says she never agreed to any promotion and had to throw out all the dip. Heluva Good!

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

Even in 2026, GPT-4 continues to be a major player in the generative AI scene. Released back in 2023, it really set a new bar ...

The ‘Getting Started’ section is like the quick-start guide for a new gadget. It gives you the most important first steps, ...